CHEMOTHERAPY
GENERAL
PRINCIPLES
n
DNA Review
– Double
helix structure
– Chromosomes
that direct cellular life
– Directs
formation of RNA
– Protein
synthesis dependent on mRNA and tRNA
– Each
3 codones make up an amino acid
– Chemotherapy
can block synthesis
GENERAL
PRINCIPLES
n
Cancer Cell Cycle
– S
Phase is replicating phase
n
Most drugs work on this phase
– G°
Phase is non-replicating phase
n
No drugs can work on this phase
n
Drug Resistance
– Innate
– Acquired
GENERAL
PRINCIPLES
n
Drugs kill by first order kinetics
– Effective
therapy kills 99.9% of tumor cells
n
Importance of scheduling regimens
n
Advantages of combination therapy
ALKYLATING
AGENTS
n
Causes Abnormal pairing of DNA strands
n
Toxicities - Rapid growing normal
tissues - hematopoetic (blood cells), GI, hair, gonads
n
Bone marrow depression occurs slowly and
recovers in 4 to 6 weeks
NITROSOUREAS
n
Crosses Blood Brain Barrier
n
Effective against CNS tumors
CISPLATIN
n
Extremely Toxic
– Nephrotoxicity
- must use fluids and diuretics to protect kidneys
– Extensive
nausea/vomit
n
Prevention includes
– marijuana
derivative dronabinol (Marinol®)
– metoclopramide
(Reglan®)
– 5HT-3
Antagonist - ondasetron (Zofran®), granisetron (Kytril®)
DOXORUBICIN
n
Toxicities
– Bone
marrow aplasia
– Delayed
cardiotoxicity leading to CHF
n
Cannot exceed maximum cumulative
lifetime dose
BLEOMYCIN
n
Used in combination
n
Toxicities
– Pneumonitis
– Minimal
effect on bone marrow
METHOTREXATE
n
Interferes with activiation of folic
acid to tetrahydrofolate
n
May require leucovorin rescue
HORMONAL
THERAPY
n
Palliative therapy - not curative
n
First line therapy - less toxic
n
Sex Hormone Therapy
– Estrogens
- Tx of testosterone sensitive tumors
– Testosterone
- Tx of estrogen sensitive tumors
– Progesterone
- Tx of uterine cancers
ANTI-ESTROGENS
n
Palliative therapy of breast cancer
n
Prevention of breast cancer
n
Possible adverse reaction of uterine
cancer
CORTICOSTEROIDS
n
Adjunct therapy
– lymphomas
– leukemias
VINCRISTINE
n
Used in combination
n
Toxicities
– Neurologic
numbness and weakness
– Minimal
effects on bone marrow
IMMUNOADJUVANT
n
Levamisole
n
BCG Vaccine
n
Interferons
n
Laetrile ??
TOXICITY
REVIEW
n
Nausea/vomiting
– Pretreat
prior to therapy
n
Alopecia
n
Bone Marrow Depression
– Treat
with filgrastim (Neupogen®)
n
Extravasation of vesicant drugs
– Prevented
with careful administration
MISCELLANEOUS
n
COMBINATION THERAPY REGIMENS
n
DOSE BY SURFACE AREA (mg/M˛)